Login to Your Account



Still A Chance In Melanoma

Genasense Not Approvable' In CLL; Europe's Ruling Next

By Randall Osborne


Monday, December 18, 2006
Awaiting a decision from overseas regulators on the chemotherapy booster Genasense for advanced melanoma, Genta Inc. is deciding its next steps in the U.S., after the FDA declared the product non-approvable for chronic lymphocytic leukemia. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription